Yayın:
Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKırımlıoğlu, Gülsel Yurtdaş
dc.contributor.authorBÜYÜKKÖROĞLU, GÜLAY
dc.contributor.authorÖZER, SİNAN
dc.contributor.authorYazan, Yasemin
dc.contributor.orcid0000-0001-8897-0885
dc.contributor.orcid0000-0002-9280-5783
dc.contributor.orcid0000-0002-5089-6007
dc.date.accessioned2025-11-13T10:22:18Z
dc.date.issued2020-04-28
dc.identifier.doihttps://doi.org/10.2174/1386207323666200428091945
dc.identifier.endpage341
dc.identifier.issn1386-2073
dc.identifier.issue3
dc.identifier.openalexW3020290982
dc.identifier.startpage328
dc.identifier.urihttps://hdl.handle.net/11421/3945
dc.identifier.urihttps://doi.org/10.2174/1386207323666200428091945
dc.identifier.volume24
dc.language.isoen
dc.relation.ispartofCombinatorial Chemistry & High Throughput Screening
dc.rightsrestrictedAccess
dc.subjectZeta potential
dc.subjectMOX fuel
dc.subjectBioavailability
dc.subjectParticle size
dc.subjectNanoparticle
dc.subjectMaterials science
dc.subjectNuclear chemistry
dc.subjectMoxifloxacin
dc.subjectChemistry
dc.subjectChromatography
dc.subjectNanotechnology
dc.subjectPharmacology
dc.subjectMedicine
dc.subjectAntibiotics
dc.titleMoxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5030894826
local.authorid.openalexA5039206093
local.authorid.openalexA5081405899
local.authorid.openalexA5005967372

Dosyalar

Koleksiyonlar

Publications